Hard to Treat Net Income
Hard To technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Hard To Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 109.6 K | Revenue | Quarterly Revenue Growth 0.057 |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 714.8 K | 750.6 K | |
| Net Income Applicable To Common Shares | 714.8 K | 750.6 K | |
| Net Income | 714.8 K | 750.6 K |
Hard | Net Income | Build AI portfolio with Hard Stock |
The evolution of Net Income for Hard to Treat provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Hard To compares to historical norms and industry peers.
Latest Hard To's Net Income Growth Pattern
Below is the plot of the Net Income of Hard to Treat over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Hard to Treat financial statement analysis. It represents the amount of money remaining after all of Hard to Treat operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Hard To's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hard To's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 621.6 K | 10 Years Trend |
|
Net Income |
| Timeline |
Hard Net Income Regression Statistics
| Arithmetic Mean | 538,690 | |
| Coefficient Of Variation | 74.41 | |
| Mean Deviation | 182,212 | |
| Median | 621,601 | |
| Standard Deviation | 400,854 | |
| Sample Variance | 160.7B | |
| Range | 1.8M | |
| R-Value | 0.46 | |
| Mean Square Error | 135.9B | |
| R-Squared | 0.21 | |
| Significance | 0.07 | |
| Slope | 36,123 | |
| Total Sum of Squares | 2.6T |
Hard Net Income History
Other Fundumenentals of Hard to Treat
Hard To Net Income component correlations
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Hard introduce new products? Factors like these will boost the valuation of Hard To. Market participants price Hard higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Hard To listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Quarterly Revenue Growth 0.057 |
Understanding Hard to Treat requires distinguishing between market price and book value, where the latter reflects Hard's accounting equity. The concept of intrinsic value - what Hard To's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Hard To's price substantially above or below its fundamental value.
Please note, there is a significant difference between Hard To's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hard To is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Hard To's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Hard To 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hard To's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hard To.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Hard To on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Hard to Treat or generate 0.0% return on investment in Hard To over 90 days. Hard To is related to or competes with Sonendo. Hard to Treat Diseases Inc. manufactures, supplies, and exports biopharmaceuticals and vaccines in China and internation... More
Hard To Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hard To's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hard to Treat upside and downside potential and time the market with a certain degree of confidence.
Hard To Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hard To's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hard To's standard deviation. In reality, there are many statistical measures that can use Hard To historical prices to predict the future Hard To's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hard To's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hard to Treat Backtested Returns
We have found zero technical indicators for Hard to Treat, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hard To are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Hard to Treat has no correlation between past and present. Overlapping area represents the amount of predictability between Hard To time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hard to Treat price movement. The serial correlation of 0.0 indicates that just 0.0% of current Hard To price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Hard Operating Income
Operating Income |
|
Based on the recorded statements, Hard to Treat reported net income of 621.6 K. This is 99.82% lower than that of the Biotechnology sector and 99.11% lower than that of the Health Care industry. The net income for all United States stocks is 99.89% higher than that of the company.
Hard Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hard To's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hard To could also be used in its relative valuation, which is a method of valuing Hard To by comparing valuation metrics of similar companies.Hard To is currently under evaluation in net income category among its peers.
Hard Fundamentals
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 254.37 K | ||||
| Shares Outstanding | 5.48 B | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 5.39 M | ||||
| Gross Profit | 1.78 M | ||||
| EBITDA | 1.03 M | ||||
| Net Income | 621.6 K | ||||
| Cash And Equivalents | 202.9 K | ||||
| Total Debt | 1.54 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 2.27 X | ||||
| Cash Flow From Operations | 655.71 K | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 109.65 K | ||||
| Total Asset | 4.56 M | ||||
| Retained Earnings | 1.4 M | ||||
| Working Capital | (508 K) | ||||
| Current Asset | 596 K | ||||
| Current Liabilities | 1.1 M | ||||
| Net Asset | 4.56 M |
About Hard To Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hard to Treat's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hard To using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hard to Treat based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hard Stock Analysis
When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.